Dr. Sutamtewagul is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 Hawkins Dr
Dept of Internal Medicine
Iowa City, IA 52242Phone+1 319-356-1616Fax+1 319-353-8383
Education & Training
Texas Tech University Health Sciences Center at LubbockResidency, Internal Medicine, 2011 - 2014
Chulalongkorn University Faculty of MedicineClass of 2008
University of Iowa Hospitals and ClinicsResidency, Internal Medicine
Certifications & Licensure
IA State Medical License 2014 - 2026- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Vitamin D in patients with low tumor-burden indolent non-Hodgkin lymphoma treated with rituximab therapy (ILyAD): a randomized, phase 3 clinical trial.Jonathan W Friedberg, Michael T Brady, Myla Strawderman, Brad S Kahl, Izidore S Lossos
Eclinicalmedicine. 2024-12-01 - 1 citationsOvercoming Tagraxofusp-Erzs Monotherapy Resistance in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) in a Real-World Clinical Setting.Prajwal Dhakal, Mario Sy, Grerk Sutamtewagul, Eric Mou, Nanmeng Yu
Journal of Immunotherapy and Precision Oncology. 2024-08-01 - Agreement between patient-reported and clinically documented symptoms of acute myeloid leukemia: Study protocol.Sena Chae, Jaewon Bae, Nayung Youn, Karen Dunn Lopez, Grerk Sutamtewagul
Journal of Advanced Nursing. 2024-07-05
Abstracts/Posters
- Methotrexate and Area Under the Curve Exposure in Patients Receiving MT-R for Primary CNS Lymphoma: A Single Institution Retrospective StudyGrerk Sutamtewagul, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Indolent Lymphoma and Vitamin D (ILyAD): A Double-Blind, Randomized, Placebo-Controlled Trial to Evaluate the Supplemental Effect of Vitamin D on Event-Free Survival i...Grerk Sutamtewagul, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
